§ Dr. StrangTo ask the Minister of Agriculture, Fisheries and Food, pursuant to his answer to the hon. Member for Harborough (Mr. Gamier), of 22 January,Official Report, column 427, if he will set out the reason he was given by the Medicines Commission for its decision that BST products manufactured by the companies Lilly Industries Ltd. and Monsanto SA/NV meet the medicines licensing criteria.
§ Mr. GummerThe additional data presented to the Medicines Commission by the companies in support of their applications for licences for BST products were judged as satisfying the concerns previously expressed by the Veterinary Products Committee, particularly in relation to the incidence of mastitis. On this basis the Commission advised that the Medicines Act licensing criteria of safety, quality and efficacy were met.